AstraZeneca Seroquel Settlement With DoJ Leaves Door Open To Possible Criminal Claims
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca's $520 million civil settlement resolves allegations the company promoted Seroquel for off-label uses and provided kickbacks to doctors; DoJ reserves the right to pursue criminal liability claims.